MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma (Q38715510)

5 September 2017

MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma (English)

1 reference

5 September 2017

1 reference

Hong-Xia Chen

1

1 reference

5 September 2017

Xiao-Xia Xu

2

1 reference

5 September 2017

Bu-Zhen Tan

3

1 reference

5 September 2017

Zhi Zhang

4

1 reference

5 September 2017

Xiao-Dong Zhou

5

1 reference

5 September 2017

20 February 2017

1 reference

Cellular Physiology and Biochemistry

5 September 2017

1 reference

5 September 2017

41

1 reference

5 September 2017

3

1 reference

5 September 2017

933-946

1 reference

SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level

5 September 2017

1 reference

Medical therapy of endometrial cancer: current status and promising novel treatments.

21 January 2018

1 reference

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2014

1 reference

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

21 January 2018

1 reference

The cell growth suppressor, mir-126, targets IRS-1

21 January 2018

1 reference

Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor

21 January 2018

1 reference

Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.

21 January 2018

1 reference

The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers

21 January 2018

1 reference

MicroRNAs and metastasis: little RNAs go a long way

21 January 2018

1 reference

Regulation of mRNA translation and stability by microRNAs

21 January 2018

1 reference

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

21 January 2018

1 reference

MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation.

21 January 2018

1 reference

miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.

21 January 2018

1 reference

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.

21 January 2018

1 reference

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

The angiogenic switch in carcinogenesis

21 January 2018

1 reference

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways

21 January 2018

1 reference

IJGO at the FIGO 2015 Congress

21 January 2018

1 reference

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

21 January 2018

1 reference

A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression

21 January 2018

1 reference

Expression and potential role of microRNA-29b in mouse early embryo development

21 January 2018

1 reference

LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.

21 January 2018

1 reference

Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma

21 January 2018

1 reference

AngiomiRs: Potential Biomarkers of Pregnancy's Vascular Pathologies

21 January 2018

1 reference

Different expression of miR-29b and VEGFA in glioma

21 January 2018

1 reference

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer.

21 January 2018

1 reference

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity

21 January 2018

1 reference

Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells

21 January 2018

1 reference

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000460510

1 reference

5 September 2017

1 reference